NPEs are coming to the life sciences industries. And that could be a good thing

A study released last Friday by Professor Robin Feldman and Harvard Fellow Dr Nicholson Price predicts that biopharmaceutical companies are about to become the next targets for “patent trolls”.

Entitled Patent Trolling: Why Bio & Pharmaceuticals…

Get unlimited access to all IAM content